We are live on ! Find out more
NA

Navellier & Associates Portfolio holdings

AUM $960M
1-Year Est. Return 79.37%
This Fund
S&P 500
This Quarter Est. Return
+4.81%
1 Year Est. Return
+79.37%
3 Year Est. Return
+262.34%
5 Year Est. Return
+412.53%
10 Year Est. Return
+2,309.54%
AUM
$605M
AUM Growth
-$94.5M
Cap. Flow
-$102M
Cap. Flow %
-16.93%
Top 10 Hldgs %
17.88%
Holding
348
New
67
Increased
76
Reduced
123
Closed
78

Top Sells

Rank Stock Value
1
KDP icon
Keurig Dr Pepper
KDP
+$10.6M
2
CLX icon
Clorox
CLX
+$10.6M
3
NI icon
NiSource
NI
+$10.1M
4
AVGO icon
Broadcom
AVGO
+$9.66M
5
HRL icon
Hormel Foods
HRL
+$9.34M

Sector Composition

Rank Sector Weight
1 Technology 14.96%
2 Healthcare 13%
3 Consumer Discretionary 10.76%
4 Industrials 10.57%
5 Consumer Staples 8.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PPBI
126
DELISTED
Pacific Premier Bancorp
PPBI
$1.22M 0.2%
34,425
-398
-1% -$12K
CRUS icon
127
Cirrus Logic
CRUS
$6.53B
$1.21M 0.2%
+21,355
New +$1.18M
LGND icon
128
Ligand Pharmaceuticals
LGND
$5.76B
$1.17M 0.19%
18,374
+2,298
+14% +$145K
PAYX icon
129
Paychex
PAYX
$41.6B
$1.16M 0.19%
19,121
+3,493
+22% +$201K
UI icon
130
Ubiquiti
UI
$33.7B
$1.13M 0.19%
19,531
+4,437
+29% +$242K
WMT icon
131
Walmart Inc
WMT
$885B
$1.11M 0.18%
48,000
+11,100
+30% +$259K
COST icon
132
Costco
COST
$422B
$1.1M 0.18%
6,900
+1,300
+23% +$198K
IDCC icon
133
InterDigital
IDCC
$7.87B
$1.1M 0.18%
+12,048
New +$966K
ABMD
134
DELISTED
Abiomed Inc
ABMD
$1.1M 0.18%
9,758
+1,717
+21% +$199K
NKE icon
135
Nike
NKE
$61.9B
$1.03M 0.17%
20,300
-1,300
-6% -$66.7K
LCII icon
136
LCI Industries
LCII
$2.49B
$1.03M 0.17%
9,555
-9,041
-49% -$899K
NTGR icon
137
NETGEAR
NTGR
$648M
$896K 0.15%
16,484
-15,890
-49% -$849K
VIVO
138
DELISTED
Meridian Bioscience Inc
VIVO
$893K 0.15%
50,463
+8,229
+19% +$145K
GKOS icon
139
Glaukos
GKOS
$9.83B
$870K 0.14%
+25,366
New +$868K
SYY icon
140
Sysco
SYY
$40.8B
$865K 0.14%
15,616
-688
-4% -$35.7K
ELLI
141
DELISTED
Ellie Mae Inc
ELLI
$862K 0.14%
10,299
-172
-2% -$15.9K
HDSN
142
Hudson Technologies
HDSN
$254M
$861K 0.14%
107,459
+46,579
+77% +$329K
CONE
143
DELISTED
CyrusOne Inc Common Stock
CONE
$855K 0.14%
19,123
-5,316
-22% -$236K
ROIC
144
DELISTED
Retail Opportunity Investments Corp.
ROIC
$843K 0.14%
39,913
-1,026
-3% -$21K
PAYC icon
145
Paycom
PAYC
$7.64B
$830K 0.14%
18,245
-3,455
-16% -$160K
CPRT icon
146
Copart
CPRT
$27B
$772K 0.13%
+111,512
New +$758K
WAL icon
147
Western Alliance Bancorporation
WAL
$8.79B
$770K 0.13%
15,809
-8,139
-34% -$350K
CZR icon
148
Caesars Entertainment
CZR
$6.06B
$759K 0.13%
44,804
-1,232
-3% -$17.3K
CBM
149
DELISTED
Cambrex Corporation
CBM
$750K 0.12%
13,894
UGI icon
150
UGI
UGI
$7.74B
$730K 0.12%
15,842
-484
-3% -$21.7K

Similar funds

Navellier & Associates's Q4 2016 Portfolio in Review

As of Q4 2016, Navellier & Associates held 348 positions worth $605M, down 14% from $699M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Navellier & Associates withdrew a net $102M in Q4 2016, closing 78 positions and reducing 123 holdings. Its most notable exit was Keurig Dr Pepper, an estimated $10.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Navellier & Associates opened a new position in First Trust Industrials/Producer Durables AlphaDEX Fund worth $7.56M.

  • Navellier & Associates's largest Q4 2016 buy was First Trust Industrials/Producer Durables AlphaDEX Fund: 230,038 shares worth $7.56M.
  • Navellier & Associates added most to Idexx Laboratories in Q4 2016, an estimated $4.57M increase.
  • Navellier & Associates's biggest Q4 2016 reduction was NiSource, cutting an estimated $10.1M.
  • Navellier & Associates fully exited Keurig Dr Pepper in Q4 2016, selling an estimated $10.6M.
  • Navellier & Associates's ten largest holdings make up 18% of its $605M portfolio in Q4 2016.
  • Navellier & Associates opened 67 new positions and closed 78 in Q4 2016.
  • Navellier & Associates's portfolio value fell 14% quarter-over-quarter to $605M.

Based on Navellier & Associates's 13F filing for Q4 2016, filed 13 Feb 2017.